胺碘酮与利多卡因治疗重症室性心律失常的效果比较

Abstract
Figure/Table
References (18)
Related Citation (15)

Download: PDF (0 KB) HTML (33 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To compare the effect of Amiodarone and Lidocaine in the treatment of severe ventricular arrhythmias.Methods Sixty-two patients with severe ventricular arrhythmias admitted to cardiology department of our hospital from February 2017 to February 2019 were selected as the research subjects,and all patients were divided into the control group(n=31)and the observation group(n=31)according to the random number table method.The control group was treated with Lidocaine,and the observation group was treated with Amiodarone.The clinical efficacy,cardiac function indexes(left ventricular ejection fraction[LVEF],left ventricular end-diastolic diameter[LVEDD],left ventricular end-systolic diameter[LVESD])before and after treatment and incidence of adverse reactions of patients were observed between the observation group and the control group.Results The total effective rate of treatment in the observation group was 96.77%,which was higher than 67.74% in the control group,and the difference was statistically significant(P＜0.05).There was no significant difference in cardiac function indexes between the two groups before treatment(P＞0.05).After treatment,the LVEF,LVEDD,and LVESD of the two groups were lower than those before treatment,and the differences were statistically significant(P＜0.05).The LVEF,LVEDD,and LVESD of the observation group after treatment were lower than those of the control group,and the differences were statistically significant(P＜0.05).The total incidence rate of adverse reactions in the observation group was 9.68%,which was lower than 35.48%in the control group,and the difference was statistically significant(P＜0.05).Conclusion Amiodarone has a good clinical efficacy on severe ventricular arrhythmia,it can effectively improve the cardiac function of patients,and has a higher safety and significant effect,which is worthy of extensive promotion in clinical practice.

Key words： Amiodarone Lidocaine Severe ventricular arrhythmia Cardiac function Adverse reactions

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LONG Jun-cheng

Cite this article:

LONG Jun-cheng. Effect comparison of Amiodarone and Lidocaine in the treatment of severe ventricular arrhythmias[J]. 中国当代医药, 2020, 27(10): 40-42.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I10/40

[1]	王玉柱.胺碘酮对急性心肌梗死合并室性心律失常患者CRP 水平的影响及临床疗效[J].中国社区医师，2019，35（2）：70-71.
[2]	陈清，陈热花，涂杳然.胺碘酮治疗重症室性心律失常的临床效果与护理干预[J].药品评价，2018，15（6）：47-49，60.
[3]	杜春蕾，郭牧，张云强.尼非卡兰与胺碘酮治疗严重室性心律失常近期疗效及安全性的对比研究[J].临床心血管病杂志，2019，35（2）：58-62.
[4]	靳飞鹏，高振华，孟银苔.胺碘酮对冠心病快速室性心律失常患者心电变化的影响[J].实用中西医结合临床，2018，18（10）：143-144.
[5]	周娜.系统护理对胺碘酮治疗心力衰竭合并室性心律失常患者的应用效果评价[J].系统医学，2018，3（7）：162-164.
[6]	王辉.胺碘酮治疗急性心肌梗死后室性心律失常的临床效果观察[J].医药论坛杂志，2017，38（6）：155-156.
[7]	孙蓉.胺碘酮联合利多卡因对急性心肌梗死并发室性心律失常的疗效及安全性研究[J].检验医学与临床，2017，14（1）：157-159.
[8]	袁奇.胺碘酮联合稳心颗粒治疗老年室性心律失常的临床效果[J].中国实用医药，2017，12（35）：99-100.
[9]	吴利平.胺碘酮治疗急性心肌梗死后室性心律失常患者的效果[J].医疗装备，2017，30（7）：140-141.
[10]	陈阿娣.盐酸胺碘酮治疗冠心病室性心律失常的临床效果分析[J].中国实用医药，2017，12（3）：91-92.
[11]	龙婷华.胺碘酮对室性心律失常患者临床疗效与心功能改善程度的影响[J].海峡药学，2017，29（4）：97-98.
[12]	吴敏助.胺碘酮联合琥珀酸美托洛尔缓释片急诊治疗室性心律失常效果观察[J].医学理论与实践，2017，30（8）：1129-1131.
[13]	宋诚.小剂量胺碘酮联合倍他乐克治疗肥厚性心肌病合并恶性室性心律失常的效果分析[J].河南医学研究，2018，27（9）：105-106.
[14]	孙海波.胺碘酮治疗急性心肌梗死后室性心律失常的临床效果探讨[J].中国医药指南，2017，15（24）：104-105.
[15]	张光明.门冬氨酸钾镁联合胺碘酮治疗冠心病室性心律失常的效果及对心电图PR 间期和QRS 时限的影响[J].河南医学研究，2017，26（11）：2031-2032.
[16]	卢梓添.胺碘酮治疗急诊冠心病快速心律失常的临床效果[J].中国当代医药，2019，26（19）：47-50.
[17]	徐高峰.胺碘酮联合阿托伐他汀对非缺血性心力衰竭伴恶性心律失常的疗效及炎性因子的影响分析[J].中国医药科学，2018，8（18）：56-59.
[18]	陈华，杨梅.急诊冠心病快速心律失常患者应用胺碘酮治疗的临床疗效分析[J].当代医学，2019，25（22）：69-71.